1. Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo
   YUAN PAN et al, 2015, Oncology Reports CrossRef
2. Additive effects of eukaryotic co-expression plasmid carrying GRIM-19 and LKB1 genes on breast cancer in vitro and in vivo
   WEI ZHANG et al, 2015, Molecular Medicine Reports CrossRef
3. Methylation of DACT2 Promotes Papillary Thyroid Cancer Metastasis by Activating Wnt Signaling
   Zhiyan Zhao et al, 2014, PLoS ONE CrossRef
4. Synergistic effects of co-expression plasmid-based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo
   SONGYANG LIU et al, 2014, Oncology Reports CrossRef
5. Upregulation of GRIM-19 inhibits the growth and invasion of human breast cancer cells
   WEI ZHANG et al, 2015, Molecular Medicine Reports CrossRef
6. GRIM-19 over-expression represses the proliferation and invasion of orthotopically implanted hepatocarcinoma tumors associated with downregulation of Stat3 signaling
   Dexia Kong et al, 2019, BioScience Trends CrossRef
7. Nucleic acid combinations: A new frontier for cancer treatment
   Remant Bahadur K.C. et al, 2017, Journal of Controlled Release CrossRef
8. Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non-small cell lung cancer
   LIANG CHANG et al, 2016, Oncology Letters CrossRef
9. DNA complexes as an efficient gene anticancer drug delivery therapy
   Loutfy H. Madkour, 2019, Nucleic Acids as Gene Anticancer Drug Delivery Therapy CrossRef
10. miR‐4443 targets TRIM14 to suppress metastasis and energy metabolism of papillary thyroid carcinoma (PTC) in vitro
    Xiao‐ming Zuo et al, 2021, Cell Biology International CrossRef